Piramal Pharma Limited

Price Chart

Risk-Adjusted Performance

Piramal Pharma Limited (PPLPHARMA) Price Performance

Piramal Pharma Limited (PPLPHARMA) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR148.85, up 0.92% from the previous close.

Over the past year, PPLPHARMA has traded between a low of INR136.08 and a high of INR208.28. The stock has lost 22.4% over this period. It is currently 28.5% below its 52-week high.

Piramal Pharma Limited has a market capitalization of $197.02B, with a price-to-earnings ratio of 216.20.

About Piramal Pharma Limited

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.

Compare Piramal Pharma Limited

Side-by-side comparison against top Healthcare peers.